Re:
|
Utah Medical Products, Inc. (the “Company”)
|
|
|
Registration Statement on Form S-3 (File No. 333-153361)
|
|
|
Request for Withdrawal
|
Sincerely,
|
|
Utah Medical Products, Inc.
|
|
/s/ Paul O. Richins
|
|
Paul O. Richins
|
|
Principal Financial Officer
|
_\`C!XM\&B6PT'PA-I$VGV=N&B.F.\9>W6W)$9!*(,' ML,=*YGP-X8^`OC;7_$OP'T3QEXIW^%1]CN_#-WXCN52"WEA`5X?GW20A7*`E MF",,87"UL_M;Z=XAUO\`9+\7:Y\5>,O!]XV@>-="\<7-UX2UN>!@DBM:6@>WF'66TFVE'4="`R_,@H M`U?B3XY^#'CS0+;X+W?A35-5NI];EM-(T#2@(;A9=,F1CLR M]0H!)VG:^"?PVT/PS +4[J1](U'Q`UQ9S27#>?+/$B3/&P9Y M&Z@%6W#`[^+_``5N_''@GXNQ?M#?%GX::IHUEK=OK6D:S"EK) *?$MMX8T"34;F2[@GEANQI%PMJ1#Y>\ M> M'_`.BH_$#_`,+:\_\`BZ/^&>M'_P"BH_$# M_P`+:\_^+KOG=(U+NP55&22<`"OSN_X*"_\`!3G4==O+[X(_LW:\UOIL9:#6 MO%5G)B2[/1HK9A]V/L9!RW\)"\L`>N_&C]I?]C_X&^+G\#>)_P!H/XCZAJ4& M1>0Z%XKO+I;5A_!(XD"A_5021W`KD/\`AOO]B7_HK?QE_P#!U>?_`!ZOSH9F M=B[L22 +;60N=?O$CWM MTW-YIP/>OHC_`(9ZT?\`Z*C\0/\`PMKS_P"+K\GOV#?^3Q/AY_V,D/\`)J_: M"@#Y;_:3^,7[//[*OB?3_"?Q0^)?Q::ZU*P-W;'3/$UU,GE[V3DF9<'*GBO. M/^'@W[%G_12/C9_X/+C_`.2*X+_@MK_R6_PA_P!BHW_I3)7Q70!^C_AG]NS] MB;Q%KUMHD_QF^+VF+ A=DF8J/?&!WP.:^E='^"7A#Q!I=O MK>@_&3QQ>V5U$)+:[M/'EU)'*AY#*RN0P/J*_$NO>OV,OV]/B5^RAKL6D333 M:SX.N)\ZAH$TN?)R?FEMR>(Y.Y'W7Z'G#``_4/\`X9ZT?_HJ/Q`_\+:\_P#B MZTO"7P@T[PAK<>N6WCKQ;?/&C*+;5O$UQ XCX(/1D9>JNIR&4\@@BM^@`HHHH`***Y[XL?$;1/ MA%\--=^)WB)O]#T/3)KN9 [-A1[L*`/D3_@K)^V?>>`M(/[-'PTU M N,"@#US]@W_D\3X>?]C)#_`":OV@K\7_V#?^3Q M/AY_V,D/\FK]H*`/S7_X+:_\EO\`"'_8J-_Z4R5\5U]J?\%M?^2W^$/^Q4;_ M`-*9*^*Z`"BMSP)\.O%GQ)O;_3?!VFF[N=.TFXU*>W0_.T$"[I"H_B(7+8ZD M`XYXK#H`^E/^";O[9%[^S9\4X_!GB[5"/!GB2Y2+4EE8[;"X/RI=+_=`X5_5 M.>2@K]9U974.C`@C((/!%?@)7ZZ_\$P?C=JGQK_93TUO$%PTVH^&+Q]$NIY& MRTR1)&\3GN?W4B*2>I0F@#Z'HHHH`*^,_P#@LU\8KWPA\&]$^$6G2@?\);>2 M27V#SY-JT+@?0NR_]\U]F5^:/_!;+7I[CX^^%/##$^79^#Q=(.VZ:ZG0_I`M M`'QC5_POX OTB_X+<_\DA\%?\`8R3?^DYK\W:`/7/V M#?\`D\3X>?\`8R0_R:OV@K\7_P!@W_D\3X>?]C)#_)J_:"@#\U_^"VO_`"6_ MPA_V*C?^E,E?%=?:G_!;7_DM_A#_`+%1O_2F2OBN@#Z;_P""1Z))^V1I\Y6<9_W!Z5 M\/5]'?\`!*+7)])_;;\-V$1.W5+#4;:7']T6 "(H(SC^*.\NF;])5K]-:^'/^"UOPMU+6_`_A+XLZ;: M,\.AW%Q9ZE*HX1)S%Y1/_`T8?\"H`_.:OH'_`()>Z_;Z#^VQX0-TX5;Q;VU! M/]Y[27:/Q8`?C7S]6]\+/'VI_"SXDZ#\2-'!-SH>K6][$@.-_ER!BA]B`0?8 MT`?HO_P6G\,7VI_L\^'?$UJA:+2_%2K &%?C%XR\'^(_A_X MKU'P1XOTJ6RU/2KM[:^M9EPTVY >QU: M\6WNX3CE#"QW,P/'RA@>Q-?C)10![O\`\%#OVG]`_:D^/1\3>"XY?[!T;3TT M[29IHRCW*J[N\Q4\J&9S@'G:JY`)('A%%%`'UA_P1Q\,WFL?M7W&O11$P:1X M7NI9G[`R/'$H_'L?\%PO$%FNC?#[PJ&!N'NM0NV7NJ*L*#\RQ_[YKT/ M_@DK^S9J/P?^"5S\3_%NG-;ZQXT>*>"&5,/#8(#Y(.>A AWHGTOPK;KH]G(C95Y(V9IW'K^]9ESW$8-`'SI7T/_`,$K M-,N;_P#;B\(W4"Y6RM]2FFXZ*;"XC_\`0I%KYXK[0_X(J?#^;5_C;XG^)$L# M&WT3P\+1'QP)KF52.?79#)^=`'Z64444`%<9^T/\(]/^._P3\2?";4"J_P!L MZ8\5M*XXBN!AX9/^`R*C?A79T4`?@?X@T'5_"VO7OAG7[%[6^TZ[DMKRVE&& MBE1BKJ?<$$53K[I_X*Z_L@7>BZ^?VI/`.E%K#4"D/BV&%?\`CWN.%CNL#^%Q MA6/9PI_C./A:@#[B_P""5?[ `I(_V:OBYK2V^E75P6\+:I=2`1VDSMEK5 MV/"H[$LI/` O7KM]J MAE8@1VN[_ELNP,V3\R`*,D,H`!\$?%WX$?%SX$>('\-_%;P)?Z/.'*Q2SQ9A MG`_BCE7*2#W4FN1K]\=:T+0_$FGOI'B+1K2_M)/]9:WMNLL;?56!!KSJ^_8I M_9)U*]-_=?L[>$C*QRWEZ/&BD_[J@#]*`/Q?T#P[X@\5ZM#H/A?0[O4;ZX;; M!9V-LTLLA]`J@DU]T_L/_P#!*36QK%E\5?VHM,CM[>W=9M/\(.0[S,.5:ZQD M*HZ^4"2>C8&5/W5X)^%WPU^&UJ;/X>^`-&T.(KAETG3(K??8HS^-><_MV_ M%KXQ_!#]G?5/B+\%M%L[J_LI$%]<72ES8VS95KA(^DC*Q7AN`"6((4B@#A_^ M"BO[;NB_LT_#Z;X=>!-4C;QQK5H8[**W89TJW8$&Y?'W6QD1KW/S=%Y_)^22 M261I97+,Q)9F.22>YJ_XJ\5>)/''B*\\7>+];N=2U/4)S->WUW*7DF<]22?R M]@`!P*SZ`"OU>_X)+?!_4?AC^RM#XBURR$-YXNU2354#)AQ:[$B@!]00C2#V MFKX*_87_`&4]7_:J^-%KH-Q:RIX;TETNO$UZH("P!N(%;_GI(05'<# FVD<%M;0K%;P1(%2-%`"JH'0```"@":BBB@`HHHH`J:]H.B^* M=$N_#?B/2X+VPO[=X+RTN8PT 32BQXAG_V N`97]P#A5_V4 M45PWP\_X)O\`P!^%?[1<'[0'@>VN+5;:"9K7PZ^'M;:Z?@3Q$_,@52X"'(!8 M$%=H%?0-`!1110`56UG1M+\1:/=:!KEA'=65];/;W=M,N4EB=2K(P[@@D'ZU M9HH`_%/]L+]G35?V8?CMJWPVN$E;3B_VK0+N3_EXLI"3&<]V7!1O]I#[5G_L MX?LU?$W]I_X@P>`_AUI1*@J^IZK,A^SZ?#GF21OSPH^9CP!UQ^K?[6G[%OPU M_:\MM!B\;ZA=Z?/H=\9%O=.5/.FMG'[RWRP(`8A.TKP.37<_"+X,_#7X% M>#8/`?PM\*V^E:=!RRQ#,D[XP9)'/S2.>[,2>W0`4`9/[-_[.GP^_9A^&5K\ M-?`%J2J'S=1U&91YU_<$`--(1]``O15``Z9KOJ**`"BBB@`HHHH`****`"BB 8B@`HHHH`****`"BBB@`HHHH`****`/_9 ` end